S
1.78
0.07 (4.09%)
| Previous Close | 1.71 |
| Open | 1.72 |
| Volume | 126,705 |
| Avg. Volume (3M) | 200,125 |
| Market Cap | 65,334,900 |
| Price / Sales | 529.27 |
| Price / Book | 0.680 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2025 |
| Operating Margin (TTM) | -24,342.11% |
| Diluted EPS (TTM) | -0.940 |
| Quarterly Revenue Growth (YOY) | -41.50% |
| Total Debt/Equity (MRQ) | 0.60% |
| Current Ratio (MRQ) | 2.02 |
| Operating Cash Flow (TTM) | -26.74 M |
| Levered Free Cash Flow (TTM) | -16.66 M |
| Return on Assets (TTM) | -22.10% |
| Return on Equity (TTM) | -41.36% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Sera Prognostics, Inc. | Mixed | Mixed |
AIStockmoo Score
-0.3
| Analyst Consensus | -2.0 |
| Insider Activity | -2.0 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.30 |
|
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 11.34% |
| % Held by Institutions | 70.01% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| AERTS AUSTIN | - | 1.50 | -6,680 | -10,011 |
| BARLOW JANE F | 1.60 | - | 15,596 | 24,954 |
| BONIFACE JOHN J. | - | 1.49 | -1,439 | -2,144 |
| CRITCHFIELD GREGORY C | 1.60 | - | 15,596 | 24,954 |
| HARRISON ROBERT GARDNER | - | 1.49 | -667 | -994 |
| JACKSON BENJAMIN | - | 1.49 | -965 | -1,438 |
| KAMDAR KIM P. | 1.60 | - | 15,596 | 24,954 |
| KEARNEY PAUL | - | 1.49 | -1,311 | -1,953 |
| LAWRENCE SANDRA AJ | 1.60 | - | 15,596 | 24,954 |
| LINDGARDT ZHENYA | - | 1.50 | -26,386 | -39,546 |
| MIRZA MANSOOR RAZA | 1.60 | 1.55 | 15,489 | 24,788 |
| PHILLIPS JOSHUA | 1.60 | - | 15,596 | 24,954 |
| TRIMBLE RYAN | 1.60 | - | 15,596 | 24,954 |
| Aggregate Net Quantity | 71,617 | |||
| Aggregate Net Value ($) | 118,424 | |||
| Aggregate Avg. Buy ($) | 1.60 | |||
| Aggregate Avg. Sell ($) | 1.50 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LINDGARDT ZHENYA | Officer | 10 Jun 2025 | Sell (-) | 3,344 | 1.49 | 4,983 |
| HARRISON ROBERT GARDNER | Officer | 10 Jun 2025 | Sell (-) | 667 | 1.49 | 994 |
| KEARNEY PAUL | Officer | 10 Jun 2025 | Sell (-) | 1,311 | 1.49 | 1,953 |
| AERTS AUSTIN | Officer | 10 Jun 2025 | Sell (-) | 945 | 1.49 | 1,408 |
| BONIFACE JOHN J. | Officer | 10 Jun 2025 | Sell (-) | 1,439 | 1.49 | 2,144 |
| JACKSON BENJAMIN | Officer | 10 Jun 2025 | Sell (-) | 965 | 1.49 | 1,438 |
| LINDGARDT ZHENYA | Officer | 09 Jun 2025 | Sell (-) | 23,042 | 1.50 | 34,563 |
| AERTS AUSTIN | Officer | 09 Jun 2025 | Sell (-) | 5,735 | 1.50 | 8,603 |
| MIRZA MANSOOR RAZA | Director | 06 Jun 2025 | Sell (-) | 107 | 1.55 | 166 |
| BARLOW JANE F | Director | 05 Jun 2025 | Acquired (+) | 15,596 | 1.60 | 24,954 |
| LAWRENCE SANDRA AJ | Director | 05 Jun 2025 | Acquired (+) | 15,596 | 1.60 | 24,954 |
| CRITCHFIELD GREGORY C | Director | 05 Jun 2025 | Acquired (+) | 15,596 | 1.60 | 24,954 |
| KAMDAR KIM P. | Director | 05 Jun 2025 | Acquired (+) | 15,596 | 1.60 | 24,954 |
| MIRZA MANSOOR RAZA | Director | 05 Jun 2025 | Acquired (+) | 15,596 | 1.60 | 24,954 |
| PHILLIPS JOSHUA | Director | 05 Jun 2025 | Acquired (+) | 15,596 | 1.60 | 24,954 |
| TRIMBLE RYAN | Director | 05 Jun 2025 | Acquired (+) | 15,596 | 1.60 | 24,954 |
| Show more | ||||||
| Date | Type | Details |
|---|---|---|
| 29 May 2025 | Announcement | SERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES |
| 14 May 2025 | Announcement | SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE |
| 08 May 2025 | Announcement | SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER |
| 07 May 2025 | Announcement | SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS |
| 24 Apr 2025 | Announcement | Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2025 Financial Results on May 7, 2025 |
| 19 Mar 2025 | Announcement | SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN |
| 19 Mar 2025 | Announcement | SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |